NCT01272037 2026-03-18
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
21 trialsNCT01266642 2026-03-11
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT01349322 2026-03-05
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Radiation Therapy Oncology Group
Phase 3 Active not recruiting
NCT00907868 2026-02-05
BONBIS
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Active not recruiting
NCT03495011 2026-02-02
MRI Characterization of Mammographically Detected DCIS
University of Washington
Active not recruiting
NCT05340673 2026-01-28
Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer
City of Hope Medical Center
Phase 1 Active not recruiting
NCT02926911 2026-01-27
COMET
Alliance Foundation Trials, LLC.
Phase NA Active not recruiting
NCT02492607 2026-01-26
LORD
The Netherlands Cancer Institute
Phase NA Active not recruiting
NCT03878342 2026-01-23
ROMANCE
UNICANCER
Phase NA Active not recruiting
NCT05023967 2026-01-05
Metformin and Nightly Fasting in Women With Early Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT00165256 2025-12-29
Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT04537312 2025-12-22
Prospective Pilot Study of Robot-assisted Nipple Sparing Mastectomy (RNSM)
Ohio State University Comprehensive Cancer Center
Phase NA Active not recruiting
NCT02352883 2025-12-19
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Eastern Cooperative Oncology Group
Phase NA Active not recruiting
NCT01245712 2025-12-17
Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT05900986 2025-10-16
LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer
Integro Theranostics
Phase 1/2 Active not recruiting
NCT03546972 2025-10-14
Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT04009044 2025-10-09
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast
Northwestern University
Phase 2 Active not recruiting
NCT03317405 2025-08-28
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
National Cancer Institute (NCI)
Phase 1 Active not recruiting
NCT06033092 2025-08-28
TOLERANT
European Institute of Oncology
Phase 2 Active not recruiting
NCT03216421 2025-08-19
Intraoperative Radiation Therapy (IORT) in DCIS
Columbia University
Phase NA Active not recruiting
NCT01905046 2025-04-13
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting